Literature DB >> 11561171

Peroxisome proliferator-activated receptors in macrophage biology: friend or foe?

K J Moore1, M L Fitzgerald, M W Freeman.   

Abstract

Peroxisome proliferator-activated receptor (PPAR)-gamma is a nuclear hormone receptor, with a well-established role in adipogenesis and glucose metabolism. Over the past 3 years several laboratories have reported that this protein can influence macrophage responses to a variety of inflammatory stimuli. The effect of PPAR-gamma activation on macrophage lipid uptake, cholesterol efflux, and cytokine production have all recently been examined in several in-vitro culture systems. In addition, PPAR-gamma ligands have been shown to influence atherosclerotic lesion formation in murine models of that disease. This review attempts to summarize and critically evaluate that work and its implications for the use of PPAR-gamma activators in understanding and treating the pathogenetic processes that contribute to atherosclerotic plaque formation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11561171     DOI: 10.1097/00041433-200110000-00007

Source DB:  PubMed          Journal:  Curr Opin Lipidol        ISSN: 0957-9672            Impact factor:   4.776


  18 in total

Review 1.  Vascular inflammation as a therapeutic target for prevention of cardiovascular disease.

Authors:  Luther T Clark
Journal:  Curr Atheroscler Rep       Date:  2002-03       Impact factor: 5.113

2.  Cell-specific determinants of peroxisome proliferator-activated receptor gamma function in adipocytes and macrophages.

Authors:  Martina I Lefterova; David J Steger; David Zhuo; Mohammed Qatanani; Shannon E Mullican; Geetu Tuteja; Elisabetta Manduchi; Gregory R Grant; Mitchell A Lazar
Journal:  Mol Cell Biol       Date:  2010-02-22       Impact factor: 4.272

3.  Effect of peroxisome proliferator-activated receptor-gamma ligand on inflammation of human gallbladder epithelial cells.

Authors:  Guang-Dong Pan; Hong Wu; Jiang-Wen Liu; Nan-Sheng Cheng; Xian-Ze Xiong; Sheng-Fu Li; Guo-Fu Zhang; Lu-Nan Yan
Journal:  World J Gastroenterol       Date:  2005-10-14       Impact factor: 5.742

4.  Peroxisome proliferator-activated receptor gamma down-regulates follistatin in intestinal epithelial cells through SP1.

Authors:  Brian M Necela; Weidong Su; E Aubrey Thompson
Journal:  J Biol Chem       Date:  2008-09-03       Impact factor: 5.157

5.  Fatty acids regulate endothelial lipase and inflammatory markers in macrophages and in mouse aorta: a role for PPARγ.

Authors:  Un Ju Jung; Claudia Torrejon; Chuchun L Chang; Hiroko Hamai; Tilla S Worgall; Richard J Deckelbaum
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-10-04       Impact factor: 8.311

6.  PPARalpha agonists inhibit nitric oxide production by enhancing iNOS degradation in LPS-treated macrophages.

Authors:  E-L Paukkeri; T Leppänen; O Sareila; K Vuolteenaho; H Kankaanranta; E Moilanen
Journal:  Br J Pharmacol       Date:  2007-09-24       Impact factor: 8.739

Review 7.  Metabolic and additional vascular effects of thiazolidinediones.

Authors:  Fabrice M A C Martens; Frank L J Visseren; Jacinthe Lemay; Eelco J P de Koning; Ton J Rabelink
Journal:  Drugs       Date:  2002       Impact factor: 9.546

8.  Toll-like receptor 4 mediates cross-talk between peroxisome proliferator-activated receptor gamma and nuclear factor-kappaB in macrophages.

Authors:  Brian M Necela; Weidong Su; E Aubrey Thompson
Journal:  Immunology       Date:  2008-04-18       Impact factor: 7.397

9.  Expression of hepatic fat-specific protein 27 depends on the specific etiology of fatty liver.

Authors:  Daisuke Aibara; Kimihiko Matsusue; Kohei Matsuo; Soichi Takiguchi; Frank J Gonzalez; Shigeru Yamano
Journal:  Biol Pharm Bull       Date:  2013       Impact factor: 2.233

10.  Anti-obesity activity of diglyceride containing conjugated linoleic acid in C57BL/6J ob/ob mice.

Authors:  Jin-Joo Hue; Ki-Nam Lee; Jae-Hwang Jeong; Sang-Hwa Lee; Young Ho Lee; Seong-woon Jeong; Sang Yoon Nam; Young Won Yun; Beom Jun Lee
Journal:  J Vet Sci       Date:  2009-09       Impact factor: 1.672

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.